99 related articles for article (PubMed ID: 21683777)
21. Wetting effects versus ion pairs diffusivity: interactions of anionic surfactants with highly soluble cationic drugs and its impact on tablet dissolution.
Desai D; Wong B; Huang Y; Ye Q; Guo H; Huang M; Timmins P
J Pharm Sci; 2015 Jul; 104(7):2255-65. PubMed ID: 26017286
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
23. Surface composition and contact angle relationships for differently prepared solid dispersions.
Dahlberg C; Millqvist-Fureby A; Schuleit M
Eur J Pharm Biopharm; 2008 Oct; 70(2):478-85. PubMed ID: 18577450
[TBL] [Abstract][Full Text] [Related]
24. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.
Juenemann D; Jantratid E; Wagner C; Reppas C; Vertzoni M; Dressman JB
Eur J Pharm Biopharm; 2011 Feb; 77(2):257-64. PubMed ID: 21074611
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonic determination of Young's moduli of the coat and core materials of a drug tablet.
Akseli I; Becker DC; Cetinkaya C
Int J Pharm; 2009 Mar; 370(1-2):17-25. PubMed ID: 19059326
[TBL] [Abstract][Full Text] [Related]
26. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
27. Dissolution of ibuprofen from spray dried and spray chilled particles.
Elkordy AA; Essa EA
Pak J Pharm Sci; 2010 Jul; 23(3):284-90. PubMed ID: 20566441
[TBL] [Abstract][Full Text] [Related]
28. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Lenz E; Sprunk A; Kleinebudde P; Page S
Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
[TBL] [Abstract][Full Text] [Related]
29. Effect of drug substance particle size on the characteristics of granulation manufactured in a high-shear mixer.
Badawy SI; Lee TJ; Menning MM
AAPS PharmSciTech; 2000 Nov; 1(4):E33. PubMed ID: 14727898
[TBL] [Abstract][Full Text] [Related]
30. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Van Speybroeck M; Mellaerts R; Mols R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
Eur J Pharm Sci; 2010 Dec; 41(5):623-30. PubMed ID: 20850527
[TBL] [Abstract][Full Text] [Related]
31. Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate.
Sironi D; Rosenberg J; Bauer-Brandl A; Brandl M
Eur J Pharm Sci; 2017 Jan; 96():20-27. PubMed ID: 27597143
[TBL] [Abstract][Full Text] [Related]
32. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
von Orelli J; Leuenberger H
Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
[TBL] [Abstract][Full Text] [Related]
33. Contact Angle Measurements: an Alternative Approach Towards Understanding the Mechanism of Increased Drug Dissolution from Ethylcellulose Tablets Containing Surfactant and Exploring the Relationship Between Their Contact Angles and Dissolution Behaviors.
Liu T; Hao J; Yang B; Hu B; Cui Z; Li S
AAPS PharmSciTech; 2018 May; 19(4):1582-1591. PubMed ID: 29488194
[TBL] [Abstract][Full Text] [Related]
34. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
35. Surfactant solutions and porous substrates: spreading and imbibition.
Starov VM
Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting hydrophilicity on nanostructured Si-incorporated diamond-like carbon films.
Yi JW; Moon MW; Ahmed SF; Kim H; Cha TG; Kim HY; Kim SS; Lee KR
Langmuir; 2010 Nov; 26(22):17203-9. PubMed ID: 20923155
[TBL] [Abstract][Full Text] [Related]
37. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
38. Supercritical processed starch nanosponge as a carrier for enhancement of dissolution and pharmacological efficacy of fenofibrate.
Jadhav NV; Vavia PR
Int J Biol Macromol; 2017 Jun; 99():713-720. PubMed ID: 28263809
[TBL] [Abstract][Full Text] [Related]
39. Wettability interpretation of oxygen plasma modified poly(methyl methacrylate).
Chai J; Lu F; Li B; Kwok DY
Langmuir; 2004 Dec; 20(25):10919-27. PubMed ID: 15568841
[TBL] [Abstract][Full Text] [Related]
40. Manufacturing nanosized fenofibrate by salt assisted milling.
Mochalin VN; Sagar A; Gour S; Gogotsi Y
Pharm Res; 2009 Jun; 26(6):1365-70. PubMed ID: 19224343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
